These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Continuous infusion of high-dose cytosine arabinoside for treatment of childhood acute leukemia and non-Hodgkin's lymphoma in relapse. Jones GR; Ettinger LJ Semin Oncol; 1985 Jun; 12(2 Suppl 3):150-4. PubMed ID: 3874431 [No Abstract] [Full Text] [Related]
4. [Induction of remission by sequential treatment with cytosine arabinoside (araC/high dose) and L-asparaginase]. Martín-Aragonés G; Sanz MA; Martínez JA; Rafecas FJ; Gomis F; Lorenzo I; Sanz G; Marty ML Sangre (Barc); 1985; 30(1):15-21. PubMed ID: 3859023 [No Abstract] [Full Text] [Related]
5. [High-dose cytosine arabinoside and L-asparaginase in the treatment of refractory or recurrent acute non-lymphoblastic leukemia]. Sanz MA; Borrego D; Martín-Aragonés G; Martínez JA; Lorenzo I; Sanz G; Sayas MJ; Jarque I; Pastor E; Rafecas J Sangre (Barc); 1987; 32(4):476-81. PubMed ID: 3660187 [No Abstract] [Full Text] [Related]
6. Use of L-asparaginase and cytosine arabinoside for refractory acute lymphocytic leukemia with particular reference to T-cell leukemia. Steuber CP; Levy GJ; Nix WL; Shepherd DA; Starling KA; Fernbach DJ Med Pediatr Oncol; 1978; 5(1):33-8. PubMed ID: 311413 [TBL] [Abstract][Full Text] [Related]
7. Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia. Capizzi RL; Powell BL; Cooper MR; Stuart JJ; Muss HB; Richards F; Jackson DV; White DR; Spurr CL; Zekan PJ Semin Oncol; 1985 Jun; 12(2 Suppl 3):105-13. PubMed ID: 3892697 [No Abstract] [Full Text] [Related]
8. Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide. Tallman MS; Appelbaum FR; Amos D; Goldberg RS; Livingston RB; Mortimer J; Weiden PL; Thomas ED J Clin Oncol; 1987 Jun; 5(6):918-26. PubMed ID: 3585446 [TBL] [Abstract][Full Text] [Related]
9. High-dose cytosine arabinoside in the treatment of childhood malignancies. Lie SO; Slørdahl S Semin Oncol; 1985 Jun; 12(2 Suppl 3):160-5. PubMed ID: 3859931 [No Abstract] [Full Text] [Related]
10. Induction of remission with l-Asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia. Gahrton G; Engstedt L; Franzén S; Gullbring B; Holm G; Höglund S; Killander A; Killander D; Lockner D; Mellstedt H; Palmblad J; Reizenstein P; Skarberg KO; Swedberg B; Udén AM Cancer; 1974 Aug; 34(2):472-9. PubMed ID: 4527847 [No Abstract] [Full Text] [Related]
11. Remission induction with cytosine arabinoside and L-asparaginase in acute lymphoblastic leukaemia. McElwain TJ; Hardisty RM Br Med J; 1969 Dec; 4(5683):596-8. PubMed ID: 5261071 [TBL] [Abstract][Full Text] [Related]
12. [Intermediate-dose cytosine arabinoside therapy in refractory acute leukemia]. Ohshima A; Yoshida K; Miyazaki S; Fukushima Y; Miura AB; Endo K; Ando H; Sasaki H; Saito S; Sato I Gan To Kagaku Ryoho; 1989 Jan; 16(1):139-42. PubMed ID: 2643393 [No Abstract] [Full Text] [Related]
13. Effective combination treatment of advanced acute lymphocytic leukemia with cytosine arabinoside (NSC-63878) and L-asparaginase (NSC-109229). Ortega JA; Finklestein JZ; Ertel I; Hammond D; Karon M Cancer Chemother Rep; 1972 Jun; 56(3):363-8. PubMed ID: 19051496 [TBL] [Abstract][Full Text] [Related]
14. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma]. Shimazaki C; Fujita N; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Ijichi H Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396 [TBL] [Abstract][Full Text] [Related]
15. Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia. Zittoun R; Marie JP; Zittoun J; Marquet J; Haanen C Semin Oncol; 1985 Jun; 12(2 Suppl 3):139-43. PubMed ID: 3859928 [No Abstract] [Full Text] [Related]
16. [Intensification of treatment of lymphoblastic leukemia in children]. Michalewska D; Radwańska U Pediatr Pol; 1985 Jan; 60(1):5-13. PubMed ID: 3862059 [No Abstract] [Full Text] [Related]
17. Intermediate and high-dose cytosine arabinoside-containing regimens for induction and consolidation therapy for patients with acute lymphoblastic leukemia and lymphoblastic non-Hodgkin's lymphoma: the Leyden experience and review of the literature. Peters WG; Willemze R; Colly LP Semin Oncol; 1987 Jun; 14(2 Suppl 1):86-91. PubMed ID: 3473687 [No Abstract] [Full Text] [Related]
18. Antithrombin III during high-dose cytosine arabinoside therapy with or without asparaginase. Marra R; Pagano L; De Stefano V; Leone G; Bizzi B Acta Haematol; 1986; 75(2):96-9. PubMed ID: 3090830 [TBL] [Abstract][Full Text] [Related]
19. Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia. Pratt CB; Roberts D; Shanks E; Warmath EL; Jackson R Cancer Res; 1973 Sep; 33(9):2020-5. PubMed ID: 4516498 [No Abstract] [Full Text] [Related]
20. Short courses of cytosine arabinoside and L-asparaginase in children with acute leukemia. Ekert H; Colebatch JH; Matthews RN Cancer; 1972 Sep; 30(3):643-7. PubMed ID: 4507080 [No Abstract] [Full Text] [Related] [Next] [New Search]